US · Healthcare

iBio, Inc. Common Stock (IBIO)

Biotechnology

iBio, Inc. Common Stock (IBIO) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-03-23, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Key metrics for IBIO

P/E ratio
18.00

iBio, Inc. Common Stock (IBIO) — FAQ

What is IBIO's P/E ratio?

The price-to-earnings (P/E) ratio for iBio, Inc. Common Stock (IBIO) is 18.00 (data as of 2026-03-23).

Does iBio, Inc. Common Stock pay a dividend?

Dividend yield is not available in the current snapshot for iBio, Inc. Common Stock (IBIO). Check the MyAverix Finance app for the latest dividend data.

What sector is iBio, Inc. Common Stock in?

iBio, Inc. Common Stock (IBIO) is classified in the Healthcare sector (Biotechnology industry).

What exchange is IBIO listed on?

IBIO is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

App Store Google Play